Clinical Trials List
2024-03-15 - 2031-12-31
Phase III
Not yet recruiting1
Recruiting9
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-10N06.9
Isolated proteinuria with unspecified morphologic lesion
ICD-10N07.9
Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions
ICD-10N15.9
Renal tubulo-interstitial disease, unspecified
ICD-9583.9
Nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林冠宏 無
- 高芷華 無
- 洪冠予 無
- Chia-Te Liao Division of Nephrology
- Mei-Yi Wu 無
- I-jen Chiu 無
- YUNG-HO HSU Division of Nephrology
- I-WEN WU 無
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TUNG-MIN YU Division of Nephrology
- 蔡尚峰 Division of Nephrology
- CHENG-HSU CHEN Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-HSIANG CHOU Division of Nephrology
- 黃道民 Division of Nephrology
- FAN-CHI CHANG Division of Nephrology
- - - Division of Nephrology
- WEN-CHIH CHIANG Division of Nephrology
- 潘思宇 Division of Nephrology
- 陳怡婷 Division of Nephrology
- CHUN-FU LAI Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Cheng-Chia Lee 無
- 塗貽然 Division of Nephrology
- Ya-Chung Tian 無
- Wen-Hung Huang 無
- 呂悅安 Division of Nephrology
- 鄭雅蓮 Division of Nephrology
- Guan-Hsing Chen 無
- 鄭昌錡 Division of Nephrology
- 吳欣旭 無
- 陳佳晉 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
42 participants
-
Global
470 participants